Statera Biopharma, Inc. Stock Split Ratio
Statera Biopharma, Inc. had Stock Split Ratio of 5.00% as of 2015-01-28, per its 10-Q filed 2017-08-14.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2017-08-14
- 2015-01-28: Stockholders' Equity Note, Stock Split, Conversion Ratio 5.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 20.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed |
|---|---|---|
| 2015-01-28 | 5.00% 10-Q · filed 2017-08-14 | 20.00% 10-Q · filed 2015-05-07 |